Voloridge Investment Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-170,838
| Closed | -$272K | – | 1415 |
|
|
2023
Q1 | $272K | Sell |
170,838
-508,692
| -75% | -$809K | ﹤0.01% | 1284 |
|
|
2022
Q4 | $4.23M | Buy |
+679,530
| New | +$4.23M | 0.02% | 704 |
|
|
2022
Q3 | – | Sell |
-137,744
| Closed | -$876K | – | 1451 |
|
|
2022
Q2 | $876K | Sell |
137,744
-400,112
| -74% | -$2.54M | ﹤0.01% | 1219 |
|
|
2022
Q1 | $2.5M | Sell |
537,856
-104,179
| -16% | -$483K | 0.01% | 875 |
|
|
2021
Q4 | $3.21M | Buy |
642,035
+385,274
| +150% | +$1.93M | 0.02% | 896 |
|
|
2021
Q3 | $3.09M | Buy |
256,761
+191,967
| +296% | +$2.31M | 0.02% | 879 |
|
|
2021
Q2 | $1.37M | Buy |
+64,794
| New | +$1.37M | 0.01% | 1141 |
|
|
2021
Q1 | – | Sell |
-49,643
| Closed | -$1.29M | – | 1473 |
|
|
2020
Q4 | $1.29M | Buy |
+49,643
| New | +$1.29M | 0.01% | 887 |
|
|
2020
Q1 | – | Sell |
-6,441
| Closed | -$384K | – | 1175 |
|
|
2019
Q4 | $384K | Buy |
+6,441
| New | +$384K | 0.01% | 870 |
|
|
2019
Q3 | – | Sell |
-5,571
| Closed | -$259K | – | 1111 |
|
|
2019
Q2 | $259K | Buy |
+5,571
| New | +$259K | 0.01% | 669 |
|
|
2018
Q1 | – | Sell |
-67,666
| Closed | -$4.46M | – | 535 |
|
|
2017
Q4 | $4.46M | Sell |
67,666
-23,814
| -26% | -$1.57M | 0.1% | 221 |
|
|
2017
Q3 | $4.59M | Sell |
91,480
-9,839
| -10% | -$493K | 0.1% | 194 |
|
|
2017
Q2 | $4.69M | Buy |
101,319
+43,884
| +76% | +$2.03M | 0.12% | 180 |
|
|
2017
Q1 | $2.03M | Buy |
+57,435
| New | +$2.03M | 0.05% | 315 |
|
|
2015
Q4 | – | Sell |
-214,162
| Closed | -$5.05M | – | 218 |
|
|
2015
Q3 | $5.05M | Buy |
+214,162
| New | +$5.05M | 0.24% | 110 |
|